Cagrilintide
Long-acting synthetic amylin analog studied in metabolic research for its interaction with amylin and calcitonin receptor pathways. Investigated for effects on satiety signaling and gastric emptying.
Available research sizes: 5mg, 10mg
Metabolic Products
Metabolic Research Peptides
These compounds are studied in preclinical metabolic research models examining pathways related to energy metabolism and nutrient signaling. For laboratory research use only.
Research Use Only - Not for human or animal consumption.
GLOW (BPC+GHK+TB)
Research blend combining BPC-157, GHK-Cu, and TB-500. Each component studied in tissue and dermal research models for angiogenesis, fibroblast migration, and extracellular matrix activity.
Available research sizes: 70mg
KLOW (BPC+GHK+TB+KPV)
Four-component research blend (BPC-157 + GHK-Cu + TB-500 + KPV). Each peptide independently studied in tissue, dermal, and inflammatory pathway research.
Available research sizes: 80mg
RETA+TRIZ Combo
Research blend combining retatrutide and tirzepatide analogs (GLP-3 and GLP-2 class incretins). Studied in preclinical metabolic models for combined activity at GLP-1, GIP, and glucagon receptor pathways. Lyophilized.
Available research sizes: 60mg
GLP-3
Triple incretin agonist research compound. Studied for its activity at GLP-1, GIP, and glucagon receptor pathways in preclinical metabolic models. Supplied as a lyophilized white powder.
Available research sizes: 15mg, 30mg, 60mg
GLP-1
Long-acting GLP-1 receptor agonist studied in metabolic research for its effects on insulin response, gastric emptying, and central satiety pathways in preclinical models.
Available research sizes: 5mg, 10mg, 30mg
GLP-2
Dual GIP/GLP-1 agonist research compound. Investigated for combined receptor activity across GLP-1, GIP, and glucagon pathways in preclinical metabolic research.
Available research sizes: 30mg, 60mg, 100mg
AOD-9604
Synthetic 16-amino-acid fragment of the C-terminus of human growth hormone (residues 177–191). Studied for activity on lipolytic pathways without affecting IGF-1 signaling.
Available research sizes: 2mg, 5mg
5-Amino-1MQ
Small-molecule selective inhibitor of nicotinamide N-methyltransferase (NNMT). Studied in metabolic and adipose research models for its effects on cellular methylation and NAD+ salvage pathways.
Available research sizes: 10mg